{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:19:19Z","timestamp":1787667559082,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005797","name":"Vereniging Trustfonds Erasmus Universiteit Rotterdam","doi-asserted-by":"publisher","award":["97035.2023.102.265\/204\/RB"],"award-info":[{"award-number":["97035.2023.102.265\/204\/RB"]}],"id":[{"id":"10.13039\/501100005797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["09150171910002"],"award-info":[{"award-number":["09150171910002"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40271-026-00817-2","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:17:25Z","timestamp":1777375045000},"page":"725-739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severity or Incidence: Labeling Side-Effect Attributes in Discrete Choice Experiments"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2991-5442","authenticated-orcid":false,"given":"Stella Maria","family":"Marceta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7645-6168","authenticated-orcid":false,"given":"Esther Wilhelmina","family":"de Bekker-Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0110-770X","authenticated-orcid":false,"given":"Tom","family":"Van Ourti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4822-5068","authenticated-orcid":false,"given":"Jorien","family":"Veldwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"817_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s40273-025-01495-y","volume":"43","author":"SPH Nouwens","year":"2025","unstructured":"Nouwens SPH, Marceta SM, Bui M, van Dijk DMAH, Groothuis-Oudshoorn CGM, Veldwijk J, et al. The evolving landscape of discrete choice experiments in health economics: a systematic review. Pharmacoeconomics. 2025;43:879\u2013936. https:\/\/doi.org\/10.1007\/s40273-025-01495-y.","journal-title":"Pharmacoeconomics"},{"key":"817_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01395","author":"E van Overbeeke","year":"2019","unstructured":"van Overbeeke E, Janssens R, Whichello C, Sch\u00f6lin Bywall K, Sharpe J, Nikolenko N, et al. Design, conduct, and use of patient preference studies in the medical product life cycle: a multi-method study. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.01395.","journal-title":"Front Pharmacol"},{"key":"817_CR3","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jval.2016.02.019","volume":"19","author":"M Ho","year":"2016","unstructured":"Ho M, Saha A, McCleary KK, Levitan B, Christopher S, Zandlo K, et al. A framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologies. Value Health. 2016;19:746\u201350. https:\/\/doi.org\/10.1016\/j.jval.2016.02.019.","journal-title":"Value Health"},{"key":"817_CR4","unstructured":"Cowie L, Bouvy JC. Measuring patient preferences: an exploratory study to determine how patient preferences data could be used in health technology assessment (HTA). vol. 2022. 2019."},{"key":"817_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocm.2021.100309","volume":"41","author":"M Haghani","year":"2021","unstructured":"Haghani M, Bliemer MCJ, Rose JM, Oppewal H, Lancsar E. Hypothetical bias in stated choice experiments: Part I. Macro-scale analysis of literature and integrative synthesis of empirical evidence from applied economics, experimental psychology and neuroimaging. J Choice Model. 2021;41:100309. https:\/\/doi.org\/10.1016\/j.jocm.2021.100309.","journal-title":"J Choice Model"},{"key":"817_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocm.2021.100322","volume":"41","author":"M Haghani","year":"2021","unstructured":"Haghani M, Bliemer MCJ, Rose JM, Oppewal H, Lancsar E. Hypothetical bias in stated choice experiments: Part II. Conceptualisation of external validity, sources and explanations of bias and effectiveness of mitigation methods. J Choice Model. 2021;41:100322. https:\/\/doi.org\/10.1016\/j.jocm.2021.100322.","journal-title":"J Choice Model"},{"key":"817_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2009.98","author":"M Kuhn","year":"2010","unstructured":"Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol. 2010. https:\/\/doi.org\/10.1038\/msb.2009.98.","journal-title":"Mol Syst Biol"},{"key":"817_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbi.2014.03.014","volume":"51","author":"F Wang","year":"2014","unstructured":"Wang F, Zhang P, Cao N, Hu J, Sorrentino R. Exploring the associations between drug side-effects and therapeutic indications. J Biomed Inform. 2014;51:15\u201323. https:\/\/doi.org\/10.1016\/j.jbi.2014.03.014.","journal-title":"J Biomed Inform"},{"key":"817_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","volume":"16","author":"FR Johnson","year":"2013","unstructured":"Johnson FR, Lancsar E, Marshall D, Kilambi V, M\u00fchlbacher A, Regier DA, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16:3\u201313. https:\/\/doi.org\/10.1016\/j.jval.2012.08.2223.","journal-title":"Value Health"},{"key":"817_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ecco-jcc\/jjac130","volume":"17","author":"E Louis","year":"2023","unstructured":"Louis E, Siegel CA, James B, Heidenreich S, Krucien N, Ghosh S. Patients with inflammatory bowel disease have heterogeneous treatment preferences that are largely determined by the avoidance of abdominal pain and side effects [P-POWER IBD Study]. J Crohns Colitis. 2023;17:231\u20139. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac130.","journal-title":"J Crohns Colitis"},{"key":"817_CR11","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/ibd\/izae015","volume":"30","author":"G Fiorino","year":"2024","unstructured":"Fiorino G, Bent-Ennakhil N, Varriale P, Braegger F, Hoefkens E. Patient preferences for treatment attributes in inflammatory bowel disease: results from a large survey across seven European countries using a discrete choice experiment. Inflamm Bowel Dis. 2024;30:2380\u201394. https:\/\/doi.org\/10.1093\/ibd\/izae015.","journal-title":"Inflamm Bowel Dis"},{"key":"817_CR12","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1007\/s12325-025-03249-w","volume":"42","author":"M Argollo","year":"2025","unstructured":"Argollo M, An YK, Azzam N, Balderramo DC, Fadeeva O, Kuo C-J, et al. Patient preferences for treatment attributes in inflammatory bowel disease: a discrete choice experiment among patients in five non-Western countries. Adv Ther. 2025;42:3922\u201344. https:\/\/doi.org\/10.1007\/s12325-025-03249-w.","journal-title":"Adv Ther"},{"key":"817_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-072469","volume":"13","author":"Z Feng","year":"2023","unstructured":"Feng Z, Meng J, Sun Y, Xie T, Lu W, Wang G, et al. Assessment of patients\u2019 preferences for new anticancer drugs in China: a best\u2013worst discrete choice experiment on three common cancer types. BMJ Open. 2023;13:e072469. https:\/\/doi.org\/10.1136\/bmjopen-2023-072469.","journal-title":"BMJ Open"},{"key":"817_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/rheumatology\/keac397","volume":"62","author":"G Simons","year":"2023","unstructured":"Simons G, Veldwijk J, DiSantostefano RL, Englbrecht M, Radawski C, Bywall KS, et al. Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and and Romania. Rheumatology Oxford. 2023;62:596\u2013605. https:\/\/doi.org\/10.1093\/rheumatology\/keac397.","journal-title":"Rheumatology Oxford"},{"key":"817_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41927-023-00341-y","volume":"7","author":"KS Bywall","year":"2023","unstructured":"Bywall KS, Esbensen BA, Heidenvall M, Erlandsson I, Lason M, Hansson M, et al. Physical function and severe side effects matter most to patients with RA (< 5 years): a discrete choice experiment assessing preferences for personalized RA treatment. BMC Rheumatol. 2023;7:17. https:\/\/doi.org\/10.1186\/s41927-023-00341-y.","journal-title":"BMC Rheumatol"},{"key":"817_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12589-9","volume":"24","author":"S Fifer","year":"2024","unstructured":"Fifer S, Godsell J, Opat S, Hamad N, Lasica M, Forsyth C, et al. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia. BMC Cancer. 2024;24:831. https:\/\/doi.org\/10.1186\/s12885-024-12589-9.","journal-title":"BMC Cancer"},{"key":"817_CR17","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3233\/JPD-223208","volume":"12","author":"L van den Heuvel","year":"2022","unstructured":"van den Heuvel L, Hoefsloot W, Post B, Meinders MJ, Bloem BR, Stiggelbout AM, et al. Professionals\u2019 treatment preferences in the prodromal phase of Parkinson\u2019s disease: a discrete choice experiment. J Parkinsons Dis. 2022;12:1655\u201364. https:\/\/doi.org\/10.3233\/JPD-223208.","journal-title":"J Parkinsons Dis"},{"key":"817_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10067-019-04843-4","volume":"39","author":"K-A Ho","year":"2020","unstructured":"Ho K-A, Acar M, Puig A, Hutas G, Fifer S. What do Australian patients with inflammatory arthritis value in treatment? A discrete choice experiment. Clin Rheumatol. 2020;39:1077\u201389. https:\/\/doi.org\/10.1007\/s10067-019-04843-4.","journal-title":"Clin Rheumatol"},{"key":"817_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/ddg.14886","volume":"20","author":"K Faverio","year":"2022","unstructured":"Faverio K, Peitsch WK, G\u00f6rig T, Schneider\u2010Burrus S, Benzel F, Goebeler M, et al. Patient preferences in hidradenitis suppurativa (APProach\u2010HS): a discrete choice experiment. JDDG J Dtsch Dermatol Ges. 2022;20:1441\u201352. https:\/\/doi.org\/10.1111\/ddg.14886.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"817_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/2055217320910778","author":"C Poulos","year":"2020","unstructured":"Poulos C, Wakeford C, Kinter E, Mange B, Schenk T, Jhaveri M. Patient and physician preferences for multiple sclerosis treatments in Germany: a discrete-choice experiment study. Mult Scler J Exp Transl Clin. 2020. https:\/\/doi.org\/10.1177\/2055217320910778.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"817_CR21","volume-title":"The Health Belief Model and Personal Health Behavior","author":"MH Becker","year":"1974","unstructured":"Becker MH. The Health Belief Model and Personal Health Behavior, vol. 2. San Francisco: Society for Public Health Education; 1974."},{"key":"817_CR22","unstructured":"European Commission. Guideline on the readability of the labelling and package leaflet of medicinal products for human use. Brussels: 2009."},{"key":"817_CR23","unstructured":"Committee on Safety of Medicines. Always read the leaflet: getting the best information with every medicine. London: 2005."},{"key":"817_CR24","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). RDC no 47\/2009. 2010."},{"key":"817_CR25","unstructured":"swissmedic. Guidance document Product information for human medicinal products 2025."},{"key":"817_CR26","unstructured":"Guidance document: product monograph. Government of Canada. 2024."},{"key":"817_CR27","unstructured":"MEDSAFE \u2013 New Zealand Medicines and Medical Devices Safety Authority. Safety information: adverse reactions to medicines and vaccines. 2023."},{"key":"817_CR28","unstructured":"Therapeutic Goods Administration. Understanding rules for labelling biologicals. Australian Regulatory Guidelines for Biologicals (ARGB) Appendix 11. Guidance on TGO 107: mandatory labelling requirements for biologicals and human cell and tissue materials. 2024."},{"key":"817_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1521\/soco.2014.32.supp.243","volume":"32","author":"DC Molden","year":"2014","unstructured":"Molden DC. Understanding priming effects in social psychology: an overview and integration. Soc Cogn. 2014;32:243\u20139. https:\/\/doi.org\/10.1521\/soco.2014.32.supp.243.","journal-title":"Soc Cogn"},{"key":"817_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.2296719","volume":"247","author":"E Tulving","year":"1990","unstructured":"Tulving E, Schacter DL. Priming and human memory systems. Science. 1990;247:301\u20136. https:\/\/doi.org\/10.1126\/science.2296719.","journal-title":"Science"},{"key":"817_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14792779643000083","volume":"8","author":"KC Klauer","year":"1997","unstructured":"Klauer KC. Affective priming. Eur Rev Soc Psychol. 1997;8:67\u2013103. https:\/\/doi.org\/10.1080\/14792779643000083.","journal-title":"Eur Rev Soc Psychol"},{"key":"817_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3758\/s13415-022-01053-5","volume":"23","author":"S Hayakawa","year":"2023","unstructured":"Hayakawa S, Marian V. Communicating risk: how relevant and irrelevant probabilistic information influences risk perception in medical decision-making. Cogn Affect Behav Neurosci. 2023;23:678\u201390. https:\/\/doi.org\/10.3758\/s13415-022-01053-5.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"817_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40271-023-00625-y","volume":"16","author":"J Veldwijk","year":"2023","unstructured":"Veldwijk J, Marceta SM, Swait JD, Lipman SA, de Bekker-Grob EW. Taking the shortcut: simplifying heuristics in discrete choice experiments. Patient. 2023;16:301\u201315. https:\/\/doi.org\/10.1007\/s40271-023-00625-y.","journal-title":"Patient"},{"key":"817_CR34","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.vaccine.2018.01.054","volume":"36","author":"EW de Bekker-Grob","year":"2018","unstructured":"de Bekker-Grob EW, Veldwijk J, Jonker M, Donkers B, Huisman J, Buis S, et al. The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: a discrete choice experiment. Vaccine. 2018;36:1467\u201376. https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.054.","journal-title":"Vaccine"},{"key":"817_CR35","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781316136232","volume-title":"Applied choice analysis","author":"DA Hensher","year":"2015","unstructured":"Hensher DA, Rose JM, Greene WH. Applied choice analysis, vol. 2. Cambridge: Cambridge University Press; 2015. https:\/\/doi.org\/10.1017\/CBO9781316136232."},{"key":"817_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JFP Bridges","year":"2011","unstructured":"Bridges JFP, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403\u201313. https:\/\/doi.org\/10.1016\/j.jval.2010.11.013.","journal-title":"Value Health"},{"key":"817_CR37","unstructured":"Marceta SM, de Bekker-Grob EW, Van Ourti TGM, Veldwijk J. Full registration of a study (version 1): risks in patient preference studies\u2014the effect of different risk presentation formats on respondents risk comprehension, preferences and choices. Tampa (FL): 2024."},{"key":"817_CR38","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s40273-024-01431-6","volume":"42","author":"J Ride","year":"2024","unstructured":"Ride J, Goranitis I, Meng Y, LaBond C, Lancsar E. A reporting checklist for discrete choice experiments in health: the DIRECT Checklist. Pharmacoeconomics. 2024;42:1161\u201375. https:\/\/doi.org\/10.1007\/s40273-024-01431-6.","journal-title":"Pharmacoeconomics"},{"key":"817_CR39","unstructured":"Meldingen van bijwerkingen na influenza- en pneumokokken-vaccinatie. Jaarrapport vaccinatiecampagne seizoen 2023\u20132024. S\u2019Hertogenbosch: 2024."},{"key":"817_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2025.118504","volume":"384","author":"SM Marceta","year":"2025","unstructured":"Marceta SM, de Bekker-Grob EW, Veldwijk J. Visualizing risk: risk graphics\u2019 impact on patient understanding and choices in discrete choice experiments. Soc Sci Med. 2025;384:118504. https:\/\/doi.org\/10.1016\/j.socscimed.2025.118504.","journal-title":"Soc Sci Med"},{"key":"817_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1755-5345(13)70024-1","volume":"1","author":"MCJ Bliemer","year":"2008","unstructured":"Bliemer MCJ, Rose JM, Hess S. Approximation of Bayesian efficiency in experimental choice designs. J Choice Model. 2008;1:98\u2013126. https:\/\/doi.org\/10.1016\/S1755-5345(13)70024-1.","journal-title":"J Choice Model"},{"key":"817_CR42","unstructured":"ChoiceMetrics. Ngene 2023."},{"key":"817_CR43","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jval.2019.04.1924","volume":"22","author":"EW de Bekker-Grob","year":"2019","unstructured":"de Bekker-Grob EW, Swait JD, Kassahun HT, Bliemer MCJ, Jonker MF, Veldwijk J, et al. Are healthcare choices predictable? The impact of discrete choice experiment designs and models. Value Health. 2019;22:1050\u201362. https:\/\/doi.org\/10.1016\/j.jval.2019.04.1924.","journal-title":"Value Health"},{"key":"817_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pec.2020.06.031","volume":"104","author":"JCM van Weert","year":"2021","unstructured":"van Weert JCM, Alblas MC, van Dijk L, Jansen J. Preference for and understanding of graphs presenting health risk information. The role of age, health literacy, numeracy and graph literacy. Patient Educ Couns. 2021;104:109\u201317. https:\/\/doi.org\/10.1016\/j.pec.2020.06.031.","journal-title":"Patient Educ Couns"},{"key":"817_CR45","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/J.PEC.2008.07.023","volume":"73","author":"ST Hawley","year":"2008","unstructured":"Hawley ST, Zikmund-Fisher B, Ubel P, Jancovic A, Lucas T, Fagerlin A. The impact of the format of graphical presentation on health-related knowledge and treatment choices. Patient Educ Couns. 2008;73:448\u201355. https:\/\/doi.org\/10.1016\/J.PEC.2008.07.023.","journal-title":"Patient Educ Couns"},{"key":"817_CR46","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/0272989X15581800","volume":"35","author":"CD McNaughton","year":"2015","unstructured":"McNaughton CD, Cavanaugh KL, Kripalani S, Rothman RL, Wallston KA. Validation of a short, 3-item version of the Subjective Numeracy Scale. Med Decis Making. 2015;35:932\u20136. https:\/\/doi.org\/10.1177\/0272989X15581800.","journal-title":"Med Decis Making"},{"key":"817_CR47","first-page":"588","volume":"36","author":"LD Chew","year":"2004","unstructured":"Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36:588\u201394.","journal-title":"Fam Med"},{"key":"817_CR48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1542-4774.2011.01015.x","volume":"9","author":"T Dohmen","year":"2011","unstructured":"Dohmen T, Falk A, Huffman D, Sunde U, Schupp UJ\u00a8, Wagner GG. Individual risk attitudes: measurement, determinants, and behavioral consequences. J Eur Econ Assoc. 2011;9:522\u201350. https:\/\/doi.org\/10.1111\/j.1542-4774.2011.01015.x.","journal-title":"J Eur Econ Assoc"},{"key":"817_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s42409-021-00027-6","volume":"4","author":"D Nie\u00dfen","year":"2022","unstructured":"Nie\u00dfen D, Groskurth K, Kemper CJ, Rammstedt B, Lechner CM. The Optimism\u2013Pessimism Short Scale\u20132 (SOP2): a comprehensive validation of the English-language adaptation. Meas Instrum Soc Sci. 2022;4:1. https:\/\/doi.org\/10.1186\/s42409-021-00027-6.","journal-title":"Meas Instrum Soc Sci"},{"key":"817_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40271-024-00672-z","volume":"17","author":"NB Campoamor","year":"2024","unstructured":"Campoamor NB, Guerrini CJ, Brooks WB, Bridges JFP, Crossnohere NL. Pretesting discrete-choice experiments: a guide for researchers. Patient Patient-Centered Outcomes Res. 2024;17:109\u201320. https:\/\/doi.org\/10.1007\/s40271-024-00672-z.","journal-title":"Patient Patient-Centered Outcomes Res"},{"key":"817_CR51","unstructured":"R Core Team. R: a language and environment for statistical computing. 2023."},{"key":"817_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocm.2019.100170","volume":"32","author":"S Hess","year":"2019","unstructured":"Hess S, Palma D. Apollo: a flexible, powerful and customisable freeware package for choice model estimation and application. J Choice Model. 2019;32:100170. https:\/\/doi.org\/10.1016\/j.jocm.2019.100170.","journal-title":"J Choice Model"},{"key":"817_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06034-1","volume":"24","author":"MJ Doane","year":"2024","unstructured":"Doane MJ, Boeri M, Vass C, Bussberg C, Panchmatia HR, Citrome L, et al. Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder. BMC Psychiatry. 2024;24:605. https:\/\/doi.org\/10.1186\/s12888-024-06034-1.","journal-title":"BMC Psychiatry"},{"key":"817_CR54","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s11116-012-9394-9","volume":"39","author":"S Hess","year":"2012","unstructured":"Hess S, Rose JM. Can scale and coefficient heterogeneity be separated in random coefficients models? Transportation (Amst). 2012;39:1225\u201339. https:\/\/doi.org\/10.1007\/s11116-012-9394-9.","journal-title":"Transportation (Amst)"},{"key":"817_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/08870440290029520a","volume":"17","author":"D Berry","year":"2002","unstructured":"Berry D, Michas I, Bersellini E. Communicating information about medication side effects: effects on satisfaction, perceived risk to health, and intention to comply. Psychol Health. 2002;17:247\u201367. https:\/\/doi.org\/10.1080\/08870440290029520a.","journal-title":"Psychol Health"},{"key":"817_CR56","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/hex.12344","volume":"19","author":"P Knapp","year":"2016","unstructured":"Knapp P, Gardner PH, Woolf E. Combined verbal and numerical expressions increase perceived risk of medicine side-effects: a randomized controlled trial of EMA recommendations. Health Expect. 2016;19:264\u201374. https:\/\/doi.org\/10.1111\/hex.12344.","journal-title":"Health Expect"},{"key":"817_CR57","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.pec.2017.11.015","volume":"101","author":"CG Moraes","year":"2018","unstructured":"Moraes CG, da Silva Dal Pizzol T. Effect of different formats for information on side effects regarding medicine users\u2019 understanding: a randomized controlled trial. Patient Educ Couns. 2018;101:672\u20138. https:\/\/doi.org\/10.1016\/j.pec.2017.11.015.","journal-title":"Patient Educ Couns"},{"key":"817_CR58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1348\/135910708X375344","volume":"14","author":"P Knapp","year":"2009","unstructured":"Knapp P, Gardner PH, Carrigan N, Raynor DK, Woolf E. Perceived risk of medicine side effects in users of a patient information website: a study of the use of verbal descriptors, percentages and natural frequencies. Br J Health Psychol. 2009;14:579\u201394. https:\/\/doi.org\/10.1348\/135910708X375344.","journal-title":"Br J Health Psychol"},{"key":"817_CR59","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2165\/11316570-000000000-00000","volume":"32","author":"P Knapp","year":"2009","unstructured":"Knapp P, Raynor DK, Woolf E, Gardner PH, Carrigan N, McMillan B. Communicating the risk of side effects to patients. Drug Saf. 2009;32:837\u201349. https:\/\/doi.org\/10.2165\/11316570-000000000-00000.","journal-title":"Drug Saf"},{"key":"817_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/009286150604000302","volume":"40","author":"DC Berry","year":"2006","unstructured":"Berry DC, Hochhauser M. Verbal labels can triple perceived risk in clinical trials. Drug Inf J. 2006;40:249\u201358. https:\/\/doi.org\/10.1177\/009286150604000302.","journal-title":"Drug Inf J"},{"key":"817_CR61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/1354850031000135704","volume":"8","author":"DC Berry","year":"2003","unstructured":"Berry DC, Raynor DK, Knapp P. Communicating risk of medication side effects: an empirical evaluation of EU recommended terminology. Psychol Health Med. 2003;8:251\u201363. https:\/\/doi.org\/10.1080\/1354850031000135704.","journal-title":"Psychol Health Med"},{"key":"817_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/1076-898X.2.4.343","volume":"2","author":"PD Windschitl","year":"1996","unstructured":"Windschitl PD, Wells GL. Measuring psychological uncertainty: verbal versus numeric methods. J Exp Psychol Appl. 1996;2:343\u201364. https:\/\/doi.org\/10.1037\/1076-898X.2.4.343.","journal-title":"J Exp Psychol Appl"},{"key":"817_CR63","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/hex.13059","volume":"23","author":"LE Smith","year":"2020","unstructured":"Smith LE, Webster RK, Rubin GJ. A systematic review of factors associated with side\u2010effect expectations from medical interventions. Health Expect. 2020;23:731\u201358. https:\/\/doi.org\/10.1111\/hex.13059.","journal-title":"Health Expect"},{"key":"817_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.38","author":"R Eriksson","year":"2014","unstructured":"Eriksson R, Aagaard L, Jensen LJ, Borisova L, H\u00f8rl\u00fcck D, Brunak S, et al. Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA. Pharmacol Res Perspect. 2014. https:\/\/doi.org\/10.1002\/prp2.38.","journal-title":"Pharmacol Res Perspect"},{"key":"817_CR65","unstructured":"Government of Canada. Product monograph master template. 2025. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/applications-submissions\/guidance-documents\/product-monograph\/master-template.html?utm_source=chatgpt.com#b8. Accessed 30 Jul 2025."},{"key":"817_CR66","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.vaccine.2019.02.056","volume":"37","author":"F Verelst","year":"2019","unstructured":"Verelst F, Kessels R, Delva W, Beutels P, Willem L. Drivers of vaccine decision-making in South Africa: a discrete choice experiment. Vaccine. 2019;37:2079\u201389. https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.056.","journal-title":"Vaccine"},{"key":"817_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.socscimed.2018.04.038","volume":"207","author":"F Verelst","year":"2018","unstructured":"Verelst F, Willem L, Kessels R, Beutels P. Individual decisions to vaccinate one\u2019s child or oneself: a discrete choice experiment rejecting free-riding motives. Soc Sci Med. 2018;207:106\u201316. https:\/\/doi.org\/10.1016\/j.socscimed.2018.04.038.","journal-title":"Soc Sci Med"},{"key":"817_CR68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40271-022-00602-x","volume":"16","author":"FR Johnson","year":"2023","unstructured":"Johnson FR, Fairchild A, Whittington D, Srivastava AK, Gonzalez JM, Huang L. How does the public evaluate vaccines for low-incidence, severe-outcome diseases? A general-population choice experiment. Patient Patient-Cent Outcomes Res. 2023;16:139\u201351. https:\/\/doi.org\/10.1007\/s40271-022-00602-x.","journal-title":"Patient Patient-Cent Outcomes Res"},{"key":"817_CR69","unstructured":"U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). 2017."},{"key":"817_CR70","unstructured":"Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. 2018."},{"key":"817_CR71","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/hex.12215","volume":"19","author":"V Tong","year":"2016","unstructured":"Tong V, Raynor DK, Blalock SJ, Aslani P. Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leaflets. Health Expect. 2016;19:543\u201356. https:\/\/doi.org\/10.1111\/hex.12215.","journal-title":"Health Expect"},{"key":"817_CR72","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12913-015-1160-1","volume":"15","author":"V M\u00fchlbauer","year":"2015","unstructured":"M\u00fchlbauer V, M\u00fchlhauser I. Understanding adverse drug reactions in package leaflets\u2014an exploratory survey among health care professionals. BMC Health Serv Res. 2015;15:505. https:\/\/doi.org\/10.1186\/s12913-015-1160-1.","journal-title":"BMC Health Serv Res"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-026-00817-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:26:28Z","timestamp":1787664388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-026-00817-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1007\/s40271-026-00817-2","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An anonymized version of the dataset, in which any individual combinations of demographics that potentially make respondents identifiable are removed, will be made available upon reasonable request.","order":2,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki was granted by the Ethics Review Committee of the Erasmus School of Health Policy & Management (ETH2324-0316) and informed consent was obtained from all participants.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}